Osmotica Pharm Us Drug Patent Portfolio
Osmotica Pharm Us owns 1 orange book drug protected by 2 US patents Given below is the list of Osmotica Pharm Us's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6403120 | Extended release formulation of venlafaxine hydrochloride | 20 Mar, 2017 | Expired |
| US6419958 | Extended release formulation of venlafaxine hydrochloride | 20 Mar, 2017 | Expired |
Osmotica Pharm Us's Family Patents
Osmotica Pharm Us Drug List
Given below is the complete list of Osmotica Pharm Us's drugs and the patents protecting them.
1. Venlafaxine Hydrochloride
Venlafaxine Hydrochloride is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6403120 | Extended release formulation of venlafaxine hydrochloride |
20 Mar, 2017
(7 years ago)
| Expired |
| US6419958 | Extended release formulation of venlafaxine hydrochloride |
20 Mar, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Venlafaxine Hydrochloride's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List